Skip to main content
Lee Schwartzberg, MD, Oncology, Reno, NV

LeeSSchwartzbergMD

Oncology Reno, NV

Professor, Medicine-Hematology, University of Tennessee Health Science Center College of Medicine

Dr. Schwartzberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Schwartzberg's full profile

Already have an account?

  • Office

    75 Pringle Way
    Ste 801
    Reno, NV 89502
    Phone+1 775-982-5000
    Fax+1 775-982-2821

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1983 - 1987
  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1981 - 1983
  • New York Medical College
    New York Medical CollegeClass of 1980

Certifications & Licensure

  • NV State Medical License
    NV State Medical License 2021 - 2025
  • AR State Medical License
    AR State Medical License 2002 - 2023
  • MS State Medical License
    MS State Medical License 1989 - 2022
  • TN State Medical License
    TN State Medical License 1987 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2008-2014
  • Memphis Magazine: Top Doctors Castle Connolly, 2008-2014
  • America's Top Doctors for Cancer Castle Connolly, 2007-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Utilization and Early Discontinuation of First-Line Ibrutinib for Patients with Chronic Lymphocytic Leukemia Treated in the Community Oncology Setting in the United St...
    Lee S. Schwartzberg, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Safety of intravenous (IV) NEPA and oral NEPA for prevention of CINV in patients (pts) with breast cancer (BC) receiving anthracycline/cyclophosphamide (AC) chemothera... 
    2019 ASCO Annual Meeting - 6/1/2019
  • Eflapegrastim, a novel and potent long-acting GCSF for reducing chemotherapy-induced neutropenia: Integrated results from two phase III trials in breast cancer patients. 
    2019 ASCO Annual Meeting - 6/1/2019
  • 7th Community Oncology Conference 
    Global Academy for Medical Education (Elsevier), Las Vegas, Nevada - 3/30/2012

Press Mentions

  • Abstract Describing Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea in Breast Cancer Patients Accepted for Presentation at San Antonio Breast Cancer Symposium (SABCS)
    Abstract Describing Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea in Breast Cancer Patients Accepted for Presentation at San Antonio Breast Cancer Symposium (SABCS)November 4th, 2024
  • Abstract Describing Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea in Breast Cancer Patients Accepted for Presentation at San Antonio Breast Cancer Symposium (SABCS)
    Abstract Describing Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea in Breast Cancer Patients Accepted for Presentation at San Antonio Breast Cancer Symposium (SABCS)November 4th, 2024
  • Freenome Adds Renown Health as Partner for the Sanderson Study
    Freenome Adds Renown Health as Partner for the Sanderson StudyMarch 28th, 2023
  • Join now to see all

Professional Memberships